Abstract
BackgroundDE020 was a long-term, open-label (OL) roll-over study for 4 studies in the early development program of adalimumab (ADA). All 4 studies enrolled patients (pts) with active rheumatoid arthritis (RA)...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
